# Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

> **NCT04078022** · PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 58 (actual)

## Conditions studied

- Shigella

## Interventions

- **BIOLOGICAL:** SF2a-TT15 Shigella Vaccine
- **OTHER:** Placebo
- **BIOLOGICAL:** S. flexneri 2a strain 2457T Challenge Agent

## Key facts

- **NCT ID:** NCT04078022
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-02
- **Primary completion:** 2023-01-24
- **Final completion:** 2024-01-25
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078022, "Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04078022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*